Article

AMO's Tecnis CL replaces company's other silicone IOL models

Advanced Medical Optics Inc. (AMO) launched its Tecnis CL silicone IOL, which reduces spherical aberrations, improves functional vision, and improves night-driving simulator performance. This IOL replaces the company’s Z9000 and Z9001 Tecnis silicone IOL models.

Advanced Medical Optics Inc. (AMO) launched its Tecnis CL silicone IOL, which reduces spherical aberrations, improves functional vision, and improves night-driving simulator performance. This IOL replaces the company’s Z9000 and Z9001 Tecnis silicone IOL models.

The Tecnis CL IOL was introduced last month at the European Society of Cataract and Refractive Surgery meeting in London. AMO will begin shipping the lens this month in the United States, Canada, and Asia Pacific, and to Japan by mid-2007.

The blue-modified C PMMA haptics provide better visibility and easier implantation of the lens, and the frosted OptiEdge design reduces edge glare and posterior capsule opacification, according to the company.

The new IOL can be implanted with the Unfolder Silver Series Implantation Systems and the Silver Advance Cartridge through a 2.8-mm incision.

“The Tecnis CL IOL provides the same FDA-approved claims and excellent outcomes as the original Tecnis lens but with a more user-friendly design,” said AMO Corporate Vice President and Chief Marketing Officer Russ Trenary. “We expect the Tecnis CL to speed surgeon migration from older-generation silicone lenses to the superior Tecnis optical design.”

In August, the Centers for Medicare and Medicaid Services extended New Technology Intraocular Lens status to the Tecnis CL lens.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
© 2025 MJH Life Sciences

All rights reserved.